ATE264104T1 - Immunmodulierende arzneimittelzusammenstellung - Google Patents
Immunmodulierende arzneimittelzusammenstellungInfo
- Publication number
- ATE264104T1 ATE264104T1 AT98950360T AT98950360T ATE264104T1 AT E264104 T1 ATE264104 T1 AT E264104T1 AT 98950360 T AT98950360 T AT 98950360T AT 98950360 T AT98950360 T AT 98950360T AT E264104 T1 ATE264104 T1 AT E264104T1
- Authority
- AT
- Austria
- Prior art keywords
- immunomodulating
- pharmaceutical composition
- medicinal composition
- group
- rheumatism
- Prior art date
Links
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- -1 methoxyphenyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1998/004804 WO2000024397A1 (en) | 1998-10-23 | 1998-10-23 | Immunomodulatory drug composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE264104T1 true ATE264104T1 (de) | 2004-04-15 |
Family
ID=14209266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98950360T ATE264104T1 (de) | 1998-10-23 | 1998-10-23 | Immunmodulierende arzneimittelzusammenstellung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6710046B1 (de) |
| EP (1) | EP1123703B1 (de) |
| KR (1) | KR100515918B1 (de) |
| CN (1) | CN1148190C (de) |
| AT (1) | ATE264104T1 (de) |
| CA (1) | CA2347939C (de) |
| DE (1) | DE69823240T2 (de) |
| ES (1) | ES2215327T3 (de) |
| WO (1) | WO2000024397A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1579862A1 (de) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von PDE III Ihibitoren zur Reduktion der Herzgrösse in an Herzversagen leidenden Säugern |
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| EP1920785A1 (de) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Pimobendan-Cyclodextrin Komplex enthaltendes flüssiges Präparat |
| DE102007007751A1 (de) * | 2007-02-16 | 2008-08-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035333A1 (de) * | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| NL1037569C2 (en) * | 2009-12-18 | 2011-06-21 | Eurovet Animal Health B V | Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use. |
| WO2013135852A1 (en) | 2012-03-15 | 2013-09-19 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| DK3021832T3 (da) | 2013-07-19 | 2021-05-25 | Boehringer Ingelheim Vetmedica Gmbh | Konserverede etherificerede cyclodextrinderivater indeholdende flydende vandig farmaceutisk sammensætning |
| ES2593210T3 (es) | 2013-12-04 | 2016-12-07 | Boehringer Ingelheim Vetmedica Gmbh | Composiciones farmacéuticas mejoradas de pimobendán |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2516040C2 (de) * | 1974-06-10 | 1984-12-20 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| ES8101067A1 (es) | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona |
| DE3932403A1 (de) | 1989-05-12 | 1991-04-11 | Thomae Gmbh Dr K | Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US5286736A (en) | 1990-11-22 | 1994-02-15 | Dr. Karl Thomae Gmbh | Pyridyl compounds and pharmaceutical compositions containing these compounds |
| DE4237656A1 (de) * | 1992-06-13 | 1993-12-16 | Merck Patent Gmbh | Benzimidazolderivate |
| US5981470A (en) * | 1994-06-07 | 1999-11-09 | The University Of Birmingham | Uterine fibroid treatment |
| US5563143A (en) | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
| WO1997048697A1 (en) * | 1996-06-19 | 1997-12-24 | Rhone-Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| FR2751649B1 (fr) | 1996-07-26 | 1998-08-28 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP4426654B2 (ja) | 1997-09-18 | 2010-03-03 | 松森 昭 | 免疫調節用医薬組成物 |
-
1998
- 1998-10-23 CN CNB988142813A patent/CN1148190C/zh not_active Expired - Fee Related
- 1998-10-23 US US09/830,269 patent/US6710046B1/en not_active Expired - Fee Related
- 1998-10-23 AT AT98950360T patent/ATE264104T1/de not_active IP Right Cessation
- 1998-10-23 CA CA002347939A patent/CA2347939C/en not_active Expired - Fee Related
- 1998-10-23 KR KR10-2001-7005086A patent/KR100515918B1/ko not_active Expired - Fee Related
- 1998-10-23 WO PCT/JP1998/004804 patent/WO2000024397A1/ja not_active Ceased
- 1998-10-23 EP EP98950360A patent/EP1123703B1/de not_active Expired - Lifetime
- 1998-10-23 DE DE69823240T patent/DE69823240T2/de not_active Expired - Fee Related
- 1998-10-23 ES ES98950360T patent/ES2215327T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2347939A1 (en) | 2000-05-04 |
| ES2215327T3 (es) | 2004-10-01 |
| EP1123703A4 (de) | 2002-11-20 |
| CA2347939C (en) | 2006-10-10 |
| DE69823240T2 (de) | 2005-04-28 |
| US6710046B1 (en) | 2004-03-23 |
| KR100515918B1 (ko) | 2005-09-20 |
| DE69823240D1 (de) | 2004-05-19 |
| CN1148190C (zh) | 2004-05-05 |
| CN1314815A (zh) | 2001-09-26 |
| WO2000024397A1 (en) | 2000-05-04 |
| EP1123703A1 (de) | 2001-08-16 |
| KR20010107927A (ko) | 2001-12-07 |
| EP1123703B1 (de) | 2004-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0582368T3 (da) | Thienobenzodiazepinderivater til behandling af forstyrrelser i centralnervesystemet | |
| NO950297D0 (no) | Prolinamidderivater | |
| HU9603433D0 (en) | Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof | |
| EP0903347A4 (de) | ||
| PT870757E (pt) | Derivados de adamantano substituidos por fluoro | |
| ATE264104T1 (de) | Immunmodulierende arzneimittelzusammenstellung | |
| MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
| PT98773A (pt) | Processo para a preparacao de di-hidropirido/4,3-d/pirimidinas substituidas na posicao 4 e de composicoes farmaceuticas analgesicas e antiinflamatorias que as contem | |
| EP1034783A4 (de) | Amidederivaten | |
| PT89098A (pt) | Processo para a preparacao de derivados de guanina | |
| DK0617959T3 (da) | Lægemiddel til behandling af hudsygdomme | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| DK0855398T3 (da) | Sesquiterpenderivater med antiviral aktivitet | |
| AU686104B2 (en) | Substituted amidinonaphthyl ester derivatives | |
| TW275629B (de) | ||
| DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
| AU7589298A (en) | 5-{(heteroaryl)alkyl}-3-oxo-pyrido{1,2-(a)}benzimidazole-4-c arboxamide derivatives useful in treating central nervous system disorders | |
| DE69410159D1 (de) | Neue Verbindung, Leustroducsin H, ihre Herstellung und therapeutische Verwendung | |
| ATE71364T1 (de) | Fluor enthaltende vitamin-d2-derivate. | |
| DK653687D0 (da) | Middel til behandling af nyresygdomme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |